世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ハイエンド抗生物質原料の世界市場インサイト、2030年までの予測


Global High-end Antibiotic Raw Materials Market Insights, Forecast to 2030

ハイエンド抗生物質原料の世界市場は、2024年の7億6,400万米ドルから2030年には9億7,500万米ドルに成長し、予測期間中の年間平均成長率(CAGR)は4.24%と予測されています。 ハイエンド抗生物質原料の北米市場は... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2024年7月18日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

ハイエンド抗生物質原料の世界市場は、2024年の7億6,400万米ドルから2030年には9億7,500万米ドルに成長し、予測期間中の年間平均成長率(CAGR)は4.24%と予測されています。
ハイエンド抗生物質原料の北米市場は、2025年から2030年の予測期間中にCAGR 3.76%で、2024年の5億4,000万米ドルから2030年には6億7,400万米ドルに達すると推定されます。
ハイエンド抗生物質原料の中国市場は、2025年から2030年の予測期間中に4.88%の年平均成長率で、2024年の1億9,100万ドルから増加し、2030年には2億6,060万ドルに達すると推定されます。
ハイエンド抗生物質原料のヨーロッパ市場は、2025年から2030年の予測期間中に3.95%のCAGRで、2024年に1533.7百万ドルから増加し、2030年までに1934.6百万ドルに達すると推定される。

ハイエンド抗生物質原料の世界的な主要メーカーには、United Laboratories、ACS Dobfar、NCPC、Guobang Pharma、Ruiying Pharmaceuticals、Aurobindo Pharma、CSPC、Centrient Pharmaceuticals、SHYNDEC Pharmaceuticals、HPGC、Novartisなどがあります。2023年、世界の上位5社の売上高シェアは約34.07%であった。
生産面では、本レポートは2019年から2024年まで、2030年までの予測で、ハイエンド抗生物質原料の生産量、成長率、メーカー別市場シェア、地域別市場シェア(地域レベル、国レベル)を調査している。
消費面では、ハイエンド抗生物質原料の地域別(地域レベル、国レベル)、企業別、タイプ別、用途別の売上高を2019年から2024年まで、2030年までの予測で調査しています。

レポートを含みます:
ハイエンド抗生物質原料の世界市場の概要、生産能力、生産高、収益、価格を紹介します。2019年~2023年の過去の市場収益/売上データ、2024年の予測、2030年までのCAGR予測による世界市場動向の分析。
本レポートでは、ハイエンド抗生物質原料の主要生産者を調査し、主要地域と国の消費量も提供しています。ハイエンド抗生物質原料の今後の市場可能性のハイライトと、この市場を様々なセグメントとサブセグメントに予測するための主要地域/国の注目点。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。

本レポートでは、2019年から2024年までのデータで、主要メーカーのハイエンド抗生物質原料の売上高、収益、市場シェア、業界ランキングに焦点を当てています。世界のハイエンド抗生物質原料市場における主要な利害関係者を特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。
本レポートでは、2019年から2030年までのタイプ別、用途別のセグメントデータ、売上高、収益、価格を分析しています。ハイエンド抗生物質原料の売上高、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模の評価と予測。
Joyoung Bio社、Astp社、Carbosynth社、Panpharma社、Fiercepharma社、Pharmaceutical Technology社、Western Experiment社、Hisun Pharmaceutical社、Jiangzhong Pharmaceutical社、Huahai Pharmaceutical社など、世界の主要企業の詳細な企業プロフィール。

市場区分

企業別
セントリエント製薬
ノバルティス
NCPC
シアンデック製薬
ユナイテッド・ラボラトリーズ
LKPC
瑞英製薬
Qilu抗生物質
メディヤ製薬
暁星製薬
国邦製薬
福康製薬
オーキッド製薬
オーロビンド製薬
ネクターライフサイエンス
ACSドブファル
HPGC
CSPC
フアン製薬
アペロア製薬

タイプ別
ペニシリン系
セファロスポリン系
テトラサイクリン系
カルバペネム系
その他

用途別セグメント
経口FDF
注射用FDF
その他

地域別生産量
北米
欧州
中国
インド

地域別売上高
北米
米国
カナダ
中国
アジア(中国を除く)
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東、アフリカ、中南米
ブラジル
メキシコ
アフリカ
中東


各章の概要
第1章:報告書のスコープ、各市場セグメント(タイプ別、用途別など)の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と短期・中期・長期的な展開についてハイレベルな見解を提供します。
第2章 ハイエンド抗生物質原料の世界および主要生産者(地域/国)の生産/生産量。各生産者の生産量、今後6年間の発展可能性を定量的に分析している。
第3章 ハイエンド抗生物質原料の世界、地域レベル、国レベルでの販売(消費)、収益。各地域と主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展展望、市場空間を紹介する。
第4章:ハイエンド抗生物質原料メーカーの競争環境、価格、売上高、市場シェア、業界ランキング、最新の開発計画、合併・買収情報などを詳しく分析する。
第5章:タイプ別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。
第6章:用途別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。
第7章 北米(北米):タイプ別、用途別、国別、セグメント別の売上高、収益。
第8章:ヨーロッパ(欧州):タイプ別、用途別、国別、セグメント別の売上高、収益。
第9章:中国:タイプ別、用途別、セグメント別の売上高、収益。
第10章:アジア(中国を除く):タイプ別、アプリケーション別、地域別、セグメント別の売上高、収益。
第11章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。
第12章:主要メーカーのプロフィールを提供し、製品の説明と仕様、ハイエンド抗生物質原料の売上高、収益、価格、粗利益率、最近の開発など、市場の主要企業の基本状況を詳しく紹介する。
第13章:産業チェーン、販売チャネル、主要原材料、流通業者と顧客の分析。
第14章:市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介する。
第15章:レポートの要点と結論。


ページTOPに戻る


目次

1 Study Coverage 1
1.1 High-end Antibiotic Raw Materials Product Introduction 1
1.2 Market by Type 2
1.2.1 Global High-end Antibiotic Raw Materials Market Size by Type, 2019 VS 2023 VS 2030 2
1.2.2 Penicillins 5
1.2.3 Cephalosporins 5
1.2.4 Tetracyclines 6
1.2.5 Carbapenem 7
1.3 Market by Application 8
1.3.1 Global High-end Antibiotic Raw Materials Market Size by Application, 2019 VS 2023 VS 2030 8
1.3.2 Oral FDF 10
1.3.3 Injection FDF 11
1.4 Assumptions and Limitations 11
1.5 Study Objectives 12
1.6 Years Considered 13
2 Global High-end Antibiotic Raw Materials Production 14
2.1 Global High-end Antibiotic Raw Materials Production Capacity (2019-2030) 14
2.2 Global High-end Antibiotic Raw Materials Production by Region: 2019 VS 2023 VS 2030 14
2.3 Global High-end Antibiotic Raw Materials Production by Region 17
2.3.1 Global High-end Antibiotic Raw Materials Historic Production by Region (2019-2024) 17
2.3.2 Global High-end Antibiotic Raw Materials Forecasted Production by Region (2025-2030) 18
2.3.3 Global High-end Antibiotic Raw Materials Production Market Share by Region (2019-2030) 18
2.4 North America 20
2.5 Europe 20
2.6 China 21
2.7 India 21
3 Executive Summary 22
3.1 Global High-end Antibiotic Raw Materials Revenue Estimates and Forecasts 2019-2030 22
3.2 Global High-end Antibiotic Raw Materials Revenue by Region 23
3.2.1 Global High-end Antibiotic Raw Materials Revenue by Region: 2019 VS 2023 VS 2030 23
3.2.2 Global High-end Antibiotic Raw Materials Revenue by Region (2019-2024) 26
3.2.3 Global High-end Antibiotic Raw Materials Revenue by Region (2025-2030) 26
3.2.4 Global High-end Antibiotic Raw Materials Revenue Market Share by Region (2019-2030) 27
3.3 Global High-end Antibiotic Raw Materials Sales Estimates and Forecasts 2019-2030 28
3.4 Global High-end Antibiotic Raw Materials Sales by Region 29
3.4.1 Global High-end Antibiotic Raw Materials Sales by Region: 2019 VS 2023 VS 2030 29
3.4.2 Global High-end Antibiotic Raw Materials Sales by Region (2019-2024) 30
3.4.3 Global High-end Antibiotic Raw Materials Sales by Region (2025-2030) 31
3.4.4 Global High-end Antibiotic Raw Materials Sales Market Share by Region (2019-2030) 31
3.5 North America 33
3.6 Europe 34
3.7 China 35
3.8 Asia (excluding China) 36
3.9 Middle East, Africa and Latin America 37
4 Competition by Manufacturers 38
4.1 Global High-end Antibiotic Raw Materials Sales by Manufacturers 38
4.1.1 Global High-end Antibiotic Raw Materials Sales by Manufacturers (2019-2024) 38
4.1.2 Global High-end Antibiotic Raw Materials Sales Market Share by Manufacturers (2019-2024) 39
4.2 Global High-end Antibiotic Raw Materials Revenue by Manufacturers 41
4.2.1 Global High-end Antibiotic Raw Materials Revenue by Manufacturers (2019-2024) 41
4.2.2 Global High-end Antibiotic Raw Materials Revenue Market Share by Manufacturers (2019-2024) 42
4.3 Global High-end Antibiotic Raw Materials Sales Price by Manufacturers (2019-2024) 44
4.4 Global Key Players of High-end Antibiotic Raw Materials, Industry Ranking, 2022 VS 2023 45
4.5 Analysis of Competitive Landscape 46
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 46
4.5.2 Global High-end Antibiotic Raw Materials Market by Company Type (Tier 1, Tier 2, and Tier 3) 46
4.6 Global Key Manufacturers of High-end Antibiotic Raw Materials, Manufacturing Base Distribution and Headquarters 47
4.7 Global Key Manufacturers of High-end Antibiotic Raw Materials, Date of Enter into This Industry 48
4.8 Mergers & Acquisitions, Expansion Plans 49
5 Market Size by Type 52
5.1 Global High-end Antibiotic Raw Materials Sales by Type 52
5.1.1 Global High-end Antibiotic Raw Materials Historical Sales by Type (2019-2024) 52
5.1.2 Global High-end Antibiotic Raw Materials Forecasted Sales by Type (2025-2030) 52
5.1.3 Global High-end Antibiotic Raw Materials Sales Market Share by Type (2019-2030) 53
5.2 Global High-end Antibiotic Raw Materials Revenue by Type 54
5.2.1 Global High-end Antibiotic Raw Materials Historical Revenue by Type (2019-2024) 54
5.2.2 Global High-end Antibiotic Raw Materials Forecasted Revenue by Type (2025-2030) 55
5.2.3 Global High-end Antibiotic Raw Materials Revenue Market Share by Type (2019-2030) 55
5.3 Global High-end Antibiotic Raw Materials Price by Type 56
5.3.1 Global High-end Antibiotic Raw Materials Price by Type (2019-2024) 56
5.3.2 Global High-end Antibiotic Raw Materials Price Forecast by Type (2025-2030) 57
6 Market Size by Application 58
6.1 Global High-end Antibiotic Raw Materials Sales by Application 58
6.1.1 Global High-end Antibiotic Raw Materials Historical Sales by Application (2019-2024) 58
6.1.2 Global High-end Antibiotic Raw Materials Forecasted Sales by Application (2025-2030) 58
6.1.3 Global High-end Antibiotic Raw Materials Sales Market Share by Application (2019-2030) 59
6.2 Global High-end Antibiotic Raw Materials Revenue by Application 60
6.2.1 Global High-end Antibiotic Raw Materials Historical Revenue by Application (2019-2024) 60
6.2.2 Global High-end Antibiotic Raw Materials Forecasted Revenue by Application (2025-2030) 61
6.2.3 Global High-end Antibiotic Raw Materials Revenue Market Share by Application (2019-2030) 61
6.3 Global High-end Antibiotic Raw Materials Price by Application 62
6.3.1 Global High-end Antibiotic Raw Materials Price by Application (2019-2024) 62
6.3.2 Global High-end Antibiotic Raw Materials Price Forecast by Application (2025-2030) 63
7 North America 64
7.1 North America High-end Antibiotic Raw Materials Market Size by Type 64
7.1.1 North America High-end Antibiotic Raw Materials Sales by Type (2019-2030) 64
7.1.2 North America High-end Antibiotic Raw Materials Revenue by Type (2019-2030) 65
7.2 North America High-end Antibiotic Raw Materials Market Size by Application 67
7.2.1 North America High-end Antibiotic Raw Materials Sales by Application (2019-2030) 67
7.2.2 North America High-end Antibiotic Raw Materials Revenue by Application (2019-2030) 68
7.3 North America High-end Antibiotic Raw Materials Market Size by Country 70
7.3.1 North America High-end Antibiotic Raw Materials Revenue by Country: 2019 VS 2023 VS 2030 70
7.3.2 North America High-end Antibiotic Raw Materials Revenue by Country (2019-2030) 70
7.3.3 North America High-end Antibiotic Raw Materials Sales by Country (2019-2030) 71
7.3.4 US 73
7.3.5 Canada 73
8 Europe 74
8.1 Europe High-end Antibiotic Raw Materials Market Size by Type 74
8.1.1 Europe High-end Antibiotic Raw Materials Sales by Type (2019-2030) 74
8.1.2 Europe High-end Antibiotic Raw Materials Revenue by Type (2019-2030) 75
8.2 Europe High-end Antibiotic Raw Materials Market Size by Application 77
8.2.1 Europe High-end Antibiotic Raw Materials Sales by Application (2019-2030) 77
8.2.2 Europe High-end Antibiotic Raw Materials Revenue by Application (2019-2030) 78
8.3 Europe High-end Antibiotic Raw Materials Market Size by Country 79
8.3.1 Europe High-end Antibiotic Raw Materials Revenue by Country: 2019 VS 2023 VS 2030 79
8.3.2 Europe High-end Antibiotic Raw Materials Sales by Country (2019-2030) 80
8.3.3 Europe High-end Antibiotic Raw Materials Revenue by Country (2019-2030) 81
8.3.4 Germany 83
8.3.5 France 83
8.3.6 U.K. 84
8.3.7 Italy 84
8.3.8 Russia 85
9 China 86
9.1 China High-end Antibiotic Raw Materials Market Size by Type 86
9.1.1 China High-end Antibiotic Raw Materials Sales by Type (2019-2030) 86
9.1.2 China High-end Antibiotic Raw Materials Revenue by Type (2019-2030) 87
9.2 China High-end Antibiotic Raw Materials Market Size by Application 88
9.2.1 China High-end Antibiotic Raw Materials Sales by Application (2019-2030) 88
9.2.2 China High-end Antibiotic Raw Materials Revenue by Application (2019-2030) 89
10 Asia (excluding China) 91
10.1 Asia High-end Antibiotic Raw Materials Market Size by Type 91
10.1.1 Asia High-end Antibiotic Raw Materials Sales by Type (2019-2030) 91
10.1.2 Asia High-end Antibiotic Raw Materials Revenue by Type (2019-2030) 92
10.2 Asia High-end Antibiotic Raw Materials Market Size by Application 94
10.2.1 Asia High-end Antibiotic Raw Materials Sales by Application (2019-2030) 94
10.2.2 Asia High-end Antibiotic Raw Materials Revenue by Application (2019-2030) 95
10.3 Asia High-end Antibiotic Raw Materials Market Size by Region 96
10.3.1 Asia High-end Antibiotic Raw Materials Revenue by Region: 2019 VS 2023 VS 2030 96
10.3.2 Asia High-end Antibiotic Raw Materials Revenue by Region (2019-2030) 97
10.3.3 Asia High-end Antibiotic Raw Materials Sales by Region (2019-2030) 98
10.3.4 Japan 100
10.3.5 South Korea 100
10.3.6 Australia 101
10.3.7 Southeast Asia 101
10.3.8 India 102
11 Middle East, Africa and Latin America 103
11.1 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Market Size by Type 103
11.1.1 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Sales by Type (2019-2030) 103
11.1.2 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Revenue by Type (2019-2030) 104
11.2 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Market Size by Application 106
11.2.1 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Sales by Application (2019-2030) 106
11.2.2 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Revenue by Application (2019-2030) 107
11.3 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Market Size by Country 108
11.3.1 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Revenue by Country: 2019 VS 2023 VS 2030 108
11.3.2 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Revenue by Country (2019-2030) 109
11.3.3 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Sales by Country (2019-2030) 110
11.3.4 Brazil 112
11.3.5 Mexico 112
11.3.6 Middle East 113
11.3.7 Africa 113
12 Corporate Profile 114
12.1 Centrient Pharmaceuticals 114
12.1.1 Centrient Pharmaceuticals Corporation Information 114
12.1.2 Centrient Pharmaceuticals Overview 114
12.1.3 Centrient Pharmaceuticals High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 115
12.1.4 Centrient Pharmaceuticals High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 115
12.2 Novartis 116
12.2.1 Novartis Corporation Information 116
12.2.2 Novartis Overview 116
12.2.3 Novartis High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 117
12.2.4 Novartis High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 117
12.3 NCPC 118
12.3.1 NCPC Corporation Information 118
12.3.2 NCPC Overview 118
12.3.3 NCPC High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 119
12.3.4 NCPC High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 119
12.4 SHYNDEC Pharmaceuticals 120
12.4.1 SHYNDEC Pharmaceuticals Corporation Information 120
12.4.2 SHYNDEC Pharmaceuticals Overview 121
12.4.3 SHYNDEC Pharmaceuticals High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 122
12.4.4 SHYNDEC Pharmaceuticals High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 122
12.5 United Laboratories 123
12.5.1 United Laboratories Corporation Information 123
12.5.2 United Laboratories Overview 123
12.5.3 United Laboratories High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 124
12.5.4 United Laboratories High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 125
12.6 LKPC 125
12.6.1 LKPC Corporation Information 125
12.6.2 LKPC Overview 126
12.6.3 LKPC High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 126
12.6.4 LKPC High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 127
12.7 Ruiying Pharmaceuticals 128
12.7.1 Ruiying Pharmaceuticals Corporation Information 128
12.7.2 Ruiying Pharmaceuticals Overview 128
12.7.3 Ruiying Pharmaceuticals High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 130
12.7.4 Ruiying Pharmaceuticals High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 130
12.8 Qilu Antibiotics 131
12.8.1 Qilu Antibiotics Corporation Information 131
12.8.2 Qilu Antibiotics Overview 132
12.8.3 Qilu Antibiotics High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 133
12.8.4 Qilu Antibiotics High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 133
12.9 Medya Pharma 134
12.9.1 Medya Pharma Corporation Information 134
12.9.2 Medya Pharma Overview 134
12.9.3 Medya Pharma High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 135
12.9.4 Medya Pharma High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 136
12.10 Dawnrays Pharmaceutical 136
12.10.1 Dawnrays Pharmaceutical Corporation Information 136
12.10.2 Dawnrays Pharmaceutical Overview 136
12.10.3 Dawnrays Pharmaceutical High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 137
12.10.4 Dawnrays Pharmaceutical High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 138
12.11 Guobang Pharma 138
12.11.1 Guobang Pharma Corporation Information 138
12.11.2 Guobang Pharma Overview 139
12.11.3 Guobang Pharma High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 139
12.11.4 Guobang Pharma High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 140
12.12 Fukang Pharmaceutical 140
12.12.1 Fukang Pharmaceutical Corporation Information 140
12.12.2 Fukang Pharmaceutical Overview 141
12.12.3 Fukang Pharmaceutical High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 141
12.12.4 Fukang Pharmaceutical High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 142
12.13 Orchid Pharma 142
12.13.1 Orchid Pharma Corporation Information 142
12.13.2 Orchid Pharma Overview 143
12.13.3 Orchid Pharma High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 144
12.13.4 Orchid Pharma High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 144
12.14 Aurobindo Pharma 145
12.14.1 Aurobindo Pharma Corporation Information 145
12.14.2 Aurobindo Pharma Overview 146
12.14.3 Aurobindo Pharma High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 147
12.14.4 Aurobindo Pharma High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 147
12.15 Nectar Lifesciences 148
12.15.1 Nectar Lifesciences Corporation Information 148
12.15.2 Nectar Lifesciences Overview 148
12.15.3 Nectar Lifesciences High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 149
12.15.4 Nectar Lifesciences High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 149
12.16 ACS Dobfar 150
12.16.1 ACS Dobfar Corporation Information 150
12.16.2 ACS Dobfar Overview 151
12.16.3 ACS Dobfar High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 151
12.16.4 ACS Dobfar High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 152
12.17 HPGC 152
12.17.1 HPGC Corporation Information 152
12.17.2 HPGC Overview 153
12.17.3 HPGC High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 154
12.17.4 HPGC High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 154
12.18 CSPC 155
12.18.1 CSPC Corporation Information 155
12.18.2 CSPC Overview 155
12.18.3 CSPC High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 156
12.18.4 CSPC High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 156
12.19 Fuan Pharmaceutical 157
12.19.1 Fuan Pharmaceutical Corporation Information 157
12.19.2 Fuan Pharmaceutical Overview 158
12.19.3 Fuan Pharmaceutical High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 158
12.19.4 Fuan Pharmaceutical High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 159
12.20 Apeloa Pharmaceutical 159
12.20.1 Apeloa Pharmaceutical Corporation Information 159
12.20.2 Apeloa Pharmaceutical Overview 160
12.20.3 Apeloa Pharmaceutical High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 160
12.20.4 Apeloa Pharmaceutical High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 161
13 Industry Chain and Sales Channels Analysis 162
13.1 High-end Antibiotic Raw Materials Industry Chain Analysis 162
13.2 High-end Antibiotic Raw Materials Key Raw Materials 162
13.2.1 Key Raw Materials 162
13.3 High-end Antibiotic Raw Materials Production Mode & Process 164
13.4 High-end Antibiotic Raw Materials Sales and Marketing 166
13.4.1 High-end Antibiotic Raw Materials Sales Channels 166
13.4.2 High-end Antibiotic Raw Materials Distributors 168
13.5 High-end Antibiotic Raw Materials Customers 168
14 High-end Antibiotic Raw Materials Market Dynamics 171
14.1.1 High-end Antibiotic Raw Materials Industry Trends 171
14.1.2 High-end Antibiotic Raw Materials Market Drivers 172
14.1.3 High-end Antibiotic Raw Materials Market Challenges 172
14.1.4 High-end Antibiotic Raw Materials Market Restraints 173
15 Key Findings in the Global High-end Antibiotic Raw Materials Study 175
16 Appendix 177
16.1 Research Methodology 177
16.1.1 Methodology/Research Approach 177
16.1.2 Data Source 180
16.2 Author Details 183



 

ページTOPに戻る


 

Summary

The global High-end Antibiotic Raw Materials market is projected to grow from US$ 7604 million in 2024 to US$ 9754 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.24% during the forecast period.
The North America market for High-end Antibiotic Raw Materials is estimated to increase from $ 540 million in 2024 to reach $ 674 million by 2030, at a CAGR of 3.76% during the forecast period of 2025 through 2030.
The China market for High-end Antibiotic Raw Materials is estimated to increase from $ 1961 million in 2024 to reach $ 2609.6 million by 2030, at a CAGR of 4.88% during the forecast period of 2025 through 2030.
The Europe market for High-end Antibiotic Raw Materials is estimated to increase from $ 1533.7 million in 2024 to reach $ 1934.6 million by 2030, at a CAGR of 3.95% during the forecast period of 2025 through 2030.

The global key manufacturers of High-end Antibiotic Raw Materials include United Laboratories, ACS Dobfar, NCPC, Guobang Pharma, Ruiying Pharmaceuticals, Aurobindo Pharma, CSPC, Centrient Pharmaceuticals, SHYNDEC Pharmaceuticals, HPGC, Novartis, etc. In 2023, the global top five players had a share approximately 34.07% in terms of revenue.
In terms of production side, this report researches the High-end Antibiotic Raw Materials production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of High-end Antibiotic Raw Materials by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.

Report Includes:
This report presents an overview of global market for High-end Antibiotic Raw Materials, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of High-end Antibiotic Raw Materials, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for High-end Antibiotic Raw Materials, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the High-end Antibiotic Raw Materials sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global High-end Antibiotic Raw Materials market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for High-end Antibiotic Raw Materials sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Joyoung Bio, Astp, Carbosynth, Panpharma, Fiercepharma, Pharmaceutical Technology, Western Experiment, Hisun Pharmaceutical, Jiangzhong Pharmaceutical, Huahai Pharmaceutical, etc.

Market Segmentation

By Company
Centrient Pharmaceuticals
Novartis
NCPC
SHYNDEC Pharmaceuticals
United Laboratories
LKPC
Ruiying Pharmaceuticals
Qilu Antibiotics
Medya Pharma
Dawnrays Pharmaceutical
Guobang Pharma
Fukang Pharmaceutical
Orchid Pharma
Aurobindo Pharma
Nectar Lifesciences
ACS Dobfar
HPGC
CSPC
Fuan Pharmaceutical
Apeloa Pharmaceutical

Segment by Type
Penicillins
Cephalosporins
Tetracyclines
Carbapenem
Others

Segment by Application
Oral FDF
Injection FDF
Others

Production by Region
North America
Europe
China
India

Sales by Region
North America
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
Southeast Asia
India
Australia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Africa
Middle East


Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: High-end Antibiotic Raw Materials production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of High-end Antibiotic Raw Materials in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of High-end Antibiotic Raw Materials manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (North America) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, High-end Antibiotic Raw Materials sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.



ページTOPに戻る


Table of Contents

1 Study Coverage 1
1.1 High-end Antibiotic Raw Materials Product Introduction 1
1.2 Market by Type 2
1.2.1 Global High-end Antibiotic Raw Materials Market Size by Type, 2019 VS 2023 VS 2030 2
1.2.2 Penicillins 5
1.2.3 Cephalosporins 5
1.2.4 Tetracyclines 6
1.2.5 Carbapenem 7
1.3 Market by Application 8
1.3.1 Global High-end Antibiotic Raw Materials Market Size by Application, 2019 VS 2023 VS 2030 8
1.3.2 Oral FDF 10
1.3.3 Injection FDF 11
1.4 Assumptions and Limitations 11
1.5 Study Objectives 12
1.6 Years Considered 13
2 Global High-end Antibiotic Raw Materials Production 14
2.1 Global High-end Antibiotic Raw Materials Production Capacity (2019-2030) 14
2.2 Global High-end Antibiotic Raw Materials Production by Region: 2019 VS 2023 VS 2030 14
2.3 Global High-end Antibiotic Raw Materials Production by Region 17
2.3.1 Global High-end Antibiotic Raw Materials Historic Production by Region (2019-2024) 17
2.3.2 Global High-end Antibiotic Raw Materials Forecasted Production by Region (2025-2030) 18
2.3.3 Global High-end Antibiotic Raw Materials Production Market Share by Region (2019-2030) 18
2.4 North America 20
2.5 Europe 20
2.6 China 21
2.7 India 21
3 Executive Summary 22
3.1 Global High-end Antibiotic Raw Materials Revenue Estimates and Forecasts 2019-2030 22
3.2 Global High-end Antibiotic Raw Materials Revenue by Region 23
3.2.1 Global High-end Antibiotic Raw Materials Revenue by Region: 2019 VS 2023 VS 2030 23
3.2.2 Global High-end Antibiotic Raw Materials Revenue by Region (2019-2024) 26
3.2.3 Global High-end Antibiotic Raw Materials Revenue by Region (2025-2030) 26
3.2.4 Global High-end Antibiotic Raw Materials Revenue Market Share by Region (2019-2030) 27
3.3 Global High-end Antibiotic Raw Materials Sales Estimates and Forecasts 2019-2030 28
3.4 Global High-end Antibiotic Raw Materials Sales by Region 29
3.4.1 Global High-end Antibiotic Raw Materials Sales by Region: 2019 VS 2023 VS 2030 29
3.4.2 Global High-end Antibiotic Raw Materials Sales by Region (2019-2024) 30
3.4.3 Global High-end Antibiotic Raw Materials Sales by Region (2025-2030) 31
3.4.4 Global High-end Antibiotic Raw Materials Sales Market Share by Region (2019-2030) 31
3.5 North America 33
3.6 Europe 34
3.7 China 35
3.8 Asia (excluding China) 36
3.9 Middle East, Africa and Latin America 37
4 Competition by Manufacturers 38
4.1 Global High-end Antibiotic Raw Materials Sales by Manufacturers 38
4.1.1 Global High-end Antibiotic Raw Materials Sales by Manufacturers (2019-2024) 38
4.1.2 Global High-end Antibiotic Raw Materials Sales Market Share by Manufacturers (2019-2024) 39
4.2 Global High-end Antibiotic Raw Materials Revenue by Manufacturers 41
4.2.1 Global High-end Antibiotic Raw Materials Revenue by Manufacturers (2019-2024) 41
4.2.2 Global High-end Antibiotic Raw Materials Revenue Market Share by Manufacturers (2019-2024) 42
4.3 Global High-end Antibiotic Raw Materials Sales Price by Manufacturers (2019-2024) 44
4.4 Global Key Players of High-end Antibiotic Raw Materials, Industry Ranking, 2022 VS 2023 45
4.5 Analysis of Competitive Landscape 46
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 46
4.5.2 Global High-end Antibiotic Raw Materials Market by Company Type (Tier 1, Tier 2, and Tier 3) 46
4.6 Global Key Manufacturers of High-end Antibiotic Raw Materials, Manufacturing Base Distribution and Headquarters 47
4.7 Global Key Manufacturers of High-end Antibiotic Raw Materials, Date of Enter into This Industry 48
4.8 Mergers & Acquisitions, Expansion Plans 49
5 Market Size by Type 52
5.1 Global High-end Antibiotic Raw Materials Sales by Type 52
5.1.1 Global High-end Antibiotic Raw Materials Historical Sales by Type (2019-2024) 52
5.1.2 Global High-end Antibiotic Raw Materials Forecasted Sales by Type (2025-2030) 52
5.1.3 Global High-end Antibiotic Raw Materials Sales Market Share by Type (2019-2030) 53
5.2 Global High-end Antibiotic Raw Materials Revenue by Type 54
5.2.1 Global High-end Antibiotic Raw Materials Historical Revenue by Type (2019-2024) 54
5.2.2 Global High-end Antibiotic Raw Materials Forecasted Revenue by Type (2025-2030) 55
5.2.3 Global High-end Antibiotic Raw Materials Revenue Market Share by Type (2019-2030) 55
5.3 Global High-end Antibiotic Raw Materials Price by Type 56
5.3.1 Global High-end Antibiotic Raw Materials Price by Type (2019-2024) 56
5.3.2 Global High-end Antibiotic Raw Materials Price Forecast by Type (2025-2030) 57
6 Market Size by Application 58
6.1 Global High-end Antibiotic Raw Materials Sales by Application 58
6.1.1 Global High-end Antibiotic Raw Materials Historical Sales by Application (2019-2024) 58
6.1.2 Global High-end Antibiotic Raw Materials Forecasted Sales by Application (2025-2030) 58
6.1.3 Global High-end Antibiotic Raw Materials Sales Market Share by Application (2019-2030) 59
6.2 Global High-end Antibiotic Raw Materials Revenue by Application 60
6.2.1 Global High-end Antibiotic Raw Materials Historical Revenue by Application (2019-2024) 60
6.2.2 Global High-end Antibiotic Raw Materials Forecasted Revenue by Application (2025-2030) 61
6.2.3 Global High-end Antibiotic Raw Materials Revenue Market Share by Application (2019-2030) 61
6.3 Global High-end Antibiotic Raw Materials Price by Application 62
6.3.1 Global High-end Antibiotic Raw Materials Price by Application (2019-2024) 62
6.3.2 Global High-end Antibiotic Raw Materials Price Forecast by Application (2025-2030) 63
7 North America 64
7.1 North America High-end Antibiotic Raw Materials Market Size by Type 64
7.1.1 North America High-end Antibiotic Raw Materials Sales by Type (2019-2030) 64
7.1.2 North America High-end Antibiotic Raw Materials Revenue by Type (2019-2030) 65
7.2 North America High-end Antibiotic Raw Materials Market Size by Application 67
7.2.1 North America High-end Antibiotic Raw Materials Sales by Application (2019-2030) 67
7.2.2 North America High-end Antibiotic Raw Materials Revenue by Application (2019-2030) 68
7.3 North America High-end Antibiotic Raw Materials Market Size by Country 70
7.3.1 North America High-end Antibiotic Raw Materials Revenue by Country: 2019 VS 2023 VS 2030 70
7.3.2 North America High-end Antibiotic Raw Materials Revenue by Country (2019-2030) 70
7.3.3 North America High-end Antibiotic Raw Materials Sales by Country (2019-2030) 71
7.3.4 US 73
7.3.5 Canada 73
8 Europe 74
8.1 Europe High-end Antibiotic Raw Materials Market Size by Type 74
8.1.1 Europe High-end Antibiotic Raw Materials Sales by Type (2019-2030) 74
8.1.2 Europe High-end Antibiotic Raw Materials Revenue by Type (2019-2030) 75
8.2 Europe High-end Antibiotic Raw Materials Market Size by Application 77
8.2.1 Europe High-end Antibiotic Raw Materials Sales by Application (2019-2030) 77
8.2.2 Europe High-end Antibiotic Raw Materials Revenue by Application (2019-2030) 78
8.3 Europe High-end Antibiotic Raw Materials Market Size by Country 79
8.3.1 Europe High-end Antibiotic Raw Materials Revenue by Country: 2019 VS 2023 VS 2030 79
8.3.2 Europe High-end Antibiotic Raw Materials Sales by Country (2019-2030) 80
8.3.3 Europe High-end Antibiotic Raw Materials Revenue by Country (2019-2030) 81
8.3.4 Germany 83
8.3.5 France 83
8.3.6 U.K. 84
8.3.7 Italy 84
8.3.8 Russia 85
9 China 86
9.1 China High-end Antibiotic Raw Materials Market Size by Type 86
9.1.1 China High-end Antibiotic Raw Materials Sales by Type (2019-2030) 86
9.1.2 China High-end Antibiotic Raw Materials Revenue by Type (2019-2030) 87
9.2 China High-end Antibiotic Raw Materials Market Size by Application 88
9.2.1 China High-end Antibiotic Raw Materials Sales by Application (2019-2030) 88
9.2.2 China High-end Antibiotic Raw Materials Revenue by Application (2019-2030) 89
10 Asia (excluding China) 91
10.1 Asia High-end Antibiotic Raw Materials Market Size by Type 91
10.1.1 Asia High-end Antibiotic Raw Materials Sales by Type (2019-2030) 91
10.1.2 Asia High-end Antibiotic Raw Materials Revenue by Type (2019-2030) 92
10.2 Asia High-end Antibiotic Raw Materials Market Size by Application 94
10.2.1 Asia High-end Antibiotic Raw Materials Sales by Application (2019-2030) 94
10.2.2 Asia High-end Antibiotic Raw Materials Revenue by Application (2019-2030) 95
10.3 Asia High-end Antibiotic Raw Materials Market Size by Region 96
10.3.1 Asia High-end Antibiotic Raw Materials Revenue by Region: 2019 VS 2023 VS 2030 96
10.3.2 Asia High-end Antibiotic Raw Materials Revenue by Region (2019-2030) 97
10.3.3 Asia High-end Antibiotic Raw Materials Sales by Region (2019-2030) 98
10.3.4 Japan 100
10.3.5 South Korea 100
10.3.6 Australia 101
10.3.7 Southeast Asia 101
10.3.8 India 102
11 Middle East, Africa and Latin America 103
11.1 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Market Size by Type 103
11.1.1 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Sales by Type (2019-2030) 103
11.1.2 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Revenue by Type (2019-2030) 104
11.2 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Market Size by Application 106
11.2.1 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Sales by Application (2019-2030) 106
11.2.2 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Revenue by Application (2019-2030) 107
11.3 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Market Size by Country 108
11.3.1 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Revenue by Country: 2019 VS 2023 VS 2030 108
11.3.2 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Revenue by Country (2019-2030) 109
11.3.3 Middle East, Africa and Latin America High-end Antibiotic Raw Materials Sales by Country (2019-2030) 110
11.3.4 Brazil 112
11.3.5 Mexico 112
11.3.6 Middle East 113
11.3.7 Africa 113
12 Corporate Profile 114
12.1 Centrient Pharmaceuticals 114
12.1.1 Centrient Pharmaceuticals Corporation Information 114
12.1.2 Centrient Pharmaceuticals Overview 114
12.1.3 Centrient Pharmaceuticals High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 115
12.1.4 Centrient Pharmaceuticals High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 115
12.2 Novartis 116
12.2.1 Novartis Corporation Information 116
12.2.2 Novartis Overview 116
12.2.3 Novartis High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 117
12.2.4 Novartis High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 117
12.3 NCPC 118
12.3.1 NCPC Corporation Information 118
12.3.2 NCPC Overview 118
12.3.3 NCPC High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 119
12.3.4 NCPC High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 119
12.4 SHYNDEC Pharmaceuticals 120
12.4.1 SHYNDEC Pharmaceuticals Corporation Information 120
12.4.2 SHYNDEC Pharmaceuticals Overview 121
12.4.3 SHYNDEC Pharmaceuticals High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 122
12.4.4 SHYNDEC Pharmaceuticals High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 122
12.5 United Laboratories 123
12.5.1 United Laboratories Corporation Information 123
12.5.2 United Laboratories Overview 123
12.5.3 United Laboratories High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 124
12.5.4 United Laboratories High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 125
12.6 LKPC 125
12.6.1 LKPC Corporation Information 125
12.6.2 LKPC Overview 126
12.6.3 LKPC High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 126
12.6.4 LKPC High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 127
12.7 Ruiying Pharmaceuticals 128
12.7.1 Ruiying Pharmaceuticals Corporation Information 128
12.7.2 Ruiying Pharmaceuticals Overview 128
12.7.3 Ruiying Pharmaceuticals High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 130
12.7.4 Ruiying Pharmaceuticals High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 130
12.8 Qilu Antibiotics 131
12.8.1 Qilu Antibiotics Corporation Information 131
12.8.2 Qilu Antibiotics Overview 132
12.8.3 Qilu Antibiotics High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 133
12.8.4 Qilu Antibiotics High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 133
12.9 Medya Pharma 134
12.9.1 Medya Pharma Corporation Information 134
12.9.2 Medya Pharma Overview 134
12.9.3 Medya Pharma High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 135
12.9.4 Medya Pharma High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 136
12.10 Dawnrays Pharmaceutical 136
12.10.1 Dawnrays Pharmaceutical Corporation Information 136
12.10.2 Dawnrays Pharmaceutical Overview 136
12.10.3 Dawnrays Pharmaceutical High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 137
12.10.4 Dawnrays Pharmaceutical High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 138
12.11 Guobang Pharma 138
12.11.1 Guobang Pharma Corporation Information 138
12.11.2 Guobang Pharma Overview 139
12.11.3 Guobang Pharma High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 139
12.11.4 Guobang Pharma High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 140
12.12 Fukang Pharmaceutical 140
12.12.1 Fukang Pharmaceutical Corporation Information 140
12.12.2 Fukang Pharmaceutical Overview 141
12.12.3 Fukang Pharmaceutical High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 141
12.12.4 Fukang Pharmaceutical High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 142
12.13 Orchid Pharma 142
12.13.1 Orchid Pharma Corporation Information 142
12.13.2 Orchid Pharma Overview 143
12.13.3 Orchid Pharma High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 144
12.13.4 Orchid Pharma High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 144
12.14 Aurobindo Pharma 145
12.14.1 Aurobindo Pharma Corporation Information 145
12.14.2 Aurobindo Pharma Overview 146
12.14.3 Aurobindo Pharma High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 147
12.14.4 Aurobindo Pharma High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 147
12.15 Nectar Lifesciences 148
12.15.1 Nectar Lifesciences Corporation Information 148
12.15.2 Nectar Lifesciences Overview 148
12.15.3 Nectar Lifesciences High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 149
12.15.4 Nectar Lifesciences High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 149
12.16 ACS Dobfar 150
12.16.1 ACS Dobfar Corporation Information 150
12.16.2 ACS Dobfar Overview 151
12.16.3 ACS Dobfar High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 151
12.16.4 ACS Dobfar High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 152
12.17 HPGC 152
12.17.1 HPGC Corporation Information 152
12.17.2 HPGC Overview 153
12.17.3 HPGC High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 154
12.17.4 HPGC High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 154
12.18 CSPC 155
12.18.1 CSPC Corporation Information 155
12.18.2 CSPC Overview 155
12.18.3 CSPC High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 156
12.18.4 CSPC High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 156
12.19 Fuan Pharmaceutical 157
12.19.1 Fuan Pharmaceutical Corporation Information 157
12.19.2 Fuan Pharmaceutical Overview 158
12.19.3 Fuan Pharmaceutical High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 158
12.19.4 Fuan Pharmaceutical High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 159
12.20 Apeloa Pharmaceutical 159
12.20.1 Apeloa Pharmaceutical Corporation Information 159
12.20.2 Apeloa Pharmaceutical Overview 160
12.20.3 Apeloa Pharmaceutical High-end Antibiotic Raw Materials Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 160
12.20.4 Apeloa Pharmaceutical High-end Antibiotic Raw Materials Product Model Numbers, Pictures, Descriptions and Specifications 161
13 Industry Chain and Sales Channels Analysis 162
13.1 High-end Antibiotic Raw Materials Industry Chain Analysis 162
13.2 High-end Antibiotic Raw Materials Key Raw Materials 162
13.2.1 Key Raw Materials 162
13.3 High-end Antibiotic Raw Materials Production Mode & Process 164
13.4 High-end Antibiotic Raw Materials Sales and Marketing 166
13.4.1 High-end Antibiotic Raw Materials Sales Channels 166
13.4.2 High-end Antibiotic Raw Materials Distributors 168
13.5 High-end Antibiotic Raw Materials Customers 168
14 High-end Antibiotic Raw Materials Market Dynamics 171
14.1.1 High-end Antibiotic Raw Materials Industry Trends 171
14.1.2 High-end Antibiotic Raw Materials Market Drivers 172
14.1.3 High-end Antibiotic Raw Materials Market Challenges 172
14.1.4 High-end Antibiotic Raw Materials Market Restraints 173
15 Key Findings in the Global High-end Antibiotic Raw Materials Study 175
16 Appendix 177
16.1 Research Methodology 177
16.1.1 Methodology/Research Approach 177
16.1.2 Data Source 180
16.2 Author Details 183



 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(抗生物薬)の最新刊レポート

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/06 10:26

151.06 円

160.23 円

195.43 円

ページTOPに戻る